CMS launches Dialysis Facility Compare star ratings
Today, the Centers for Medicare & Medicaid Services (CMS) added star ratings to the Dialysis Facility Compare (DFC) website. These ratings summarize performance data, making it easier for consumers to use the information on the website. These ratings also spotlight excellence in health care quality. In addition to posting the star ratings, CMS updated data on individual DFC quality measures to reflect the most recent data for the existing measures.
“Star ratings are simple to understand and are an excellent resource for patients, their families, and caregivers to use when talking to doctors about health care choices,” said CMS Administrator Marilyn Tavenner. “CMS has taken another step in its continuous commitment to improve quality measures and transparency.”
DFC joined Nursing Home Compare and Physician Compare in expanding the use of star ratings on CMS websites. The DFC rating gives a one to five-star rating based on information about the quality of care and services that a dialysis facility provides. Currently, nine DFC quality measures are being used collectively to comprise the DFC star ratings. In the future, CMS will add more measures.
In related news, CMS plans to add the Standardized Readmission Ratio (SRR) for dialysis facilities to the publicly reported quality outcome measures available on the Compare website. SRR is a measure of care coordination. SRR is not included in DFC’s star rating at this time.
DFC quality measure data is either updated quarterly or annually. CMS plans to update the DFC’s star rating on an annual basis beginning in October 2015.
Wexford canned Houghton ostensibly because Q4 numbers sucked. The stock tanks back to .60 cents when earnings are released. Wexford swoops in with a $1.50-$2 offer to go private and 3 months later a Davita deal is signed, terms undisclosed.... soon followed by a deal with the military. Scary huh?
"As Chairman, I look forward to working directly with Paul, the management team and my fellow board members to create value for Nephros shareholders.”
Nephros, Inc. a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line mid-dilution hemodiafiltration system for use with a hemodialysis machine for the treatment of chronic renal failure patients, today announced that the Company's Board of Directors has appointed Paul A. Mieyal, Ph.D. to assume the role of Acting President, Acting Chief Executive Officer, and Acting Chief Financial Officer. Dr. Mieyal succeeds John C. Houghton who has served as Nephros’ President and Chief Executive Officer since 2012 and as Acting Chief Financial Officer since June 2013. Additionally, Daron Evans has been appointed Chairman of the Board of Directors. Mr. Evans will continue to serve as Chairman of the Audit Committee.
“During Paul’s prior tenure as acting CEO, Nephros obtained FDA 510k clearance for the company’s H2H hemodiafiltration system, and he was instrumental in negotiating strategic agreements with Medica SpA and Bellco S.r.l.,” said Mr. Evans. “As Chairman, I look forward to working directly with Paul, the management team and my fellow board members to create value for Nephros shareholders.”
“Nephros has a robust and differentiated portfolio with third-party validation that our HydraGuard filter meets the U.S. Army’s stringent P248 standard, market enthusiasm for our NanoGuard products in commercial applications, and FDA clearances for our medical products in hospitals and dialysis clinics,” said Dr. Mieyal. “I am excited to work with the Nephros team again in an operational role. We have a successful history of achieving goals together, and we believe that we presently have a range of opportunities to capitalize on market dynamics and strategic relationships to grow product sales and progress toward profitability.”
Dr. Rosenberg is an accomplished professional with extensive healthcare public policy experience. Dr. Rosenberg was formerly at McKinsey & Company, a global management consulting firm, where he focused on the Healthcare Systems and Services Practice. Dr. Rosenberg specializes in driving impact for payors and providers through strategic, organizational and operational improvements, including managed care contracting, alternative reimbursement designs, and clinical operations improvement. Dr. Rosenberg received his A.B. in Economics from Harvard University and his M.D. from Yale University School of Medicine.